US Patent 11883495 Anti-CD47 antibodies and uses thereof
Patent 11883495 was granted and assigned to LePU Biopharma Co on January, 2024 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11883495 Anti-CD47 antibodies and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
